Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry A Filimonov

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Life (Basel, Switzerland)|August 28, 2025
Causal Association of Free Triiodothyronine Level with Ischemic Stroke Outcome: A Mendelian Randomization StudyDmitry A Filimonov, Vitaly V Morozov, Roman V Ishchenko, et al.
International Journal of Molecular Sciences|January 21, 2023
CLC-Pred 2.0: A Freely Available Web Application for In Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike CompoundsAlexey A Lagunin, Anastasia V Rudik, Pavel V Pogodin, et al.
Molecular Informatics|October 13, 2023
A community effort in SARS-CoV-2 drug discoveryJohannes Schimunek, Philipp Seidl, Katarina Elez, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Life (Basel, Switzerland)|August 28, 2025
Causal Association of Free Triiodothyronine Level with Ischemic Stroke Outcome: A Mendelian Randomization StudyDmitry A Filimonov, Vitaly V Morozov, Roman V Ishchenko, et al.
International Journal of Molecular Sciences|January 21, 2023
CLC-Pred 2.0: A Freely Available Web Application for In Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike CompoundsAlexey A Lagunin, Anastasia V Rudik, Pavel V Pogodin, et al.
Molecular Informatics|October 13, 2023
A community effort in SARS-CoV-2 drug discoveryJohannes Schimunek, Philipp Seidl, Katarina Elez, et al.
Pageof 5